RDHL - Redhill Biopharma Lt...About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $7.14 | Open | |
| Volume | Market Cap | 209.79M | |
| Yield | Last Dividend |
| Is Redhill Biopharma (RDHL) Stock Outpac... | 05/15/20 |
| Is (RDHL) Outperforming Other Medical Stocks This Year? | |
| Is Redhill Biopharma (RDHL) Outperformin... | 04/28/20 |
| Is (RDHL) Outperforming Other Medical Stocks This Year? | |
| RedHill's Oncology Candidate to be Teste... | 04/21/20 |
| RedHill (RDHL) inks a deal with NIAID for non-clinical testing of its investigational candidate RHB-107 to evaluate its activity against COVID-19. Sto... | |
| RedHill (RDHL) Soars: Stock Adds 9.2% in... | 04/15/20 |
| RedHill (RDHL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes. | |
| Stock Alert: RedHill Biopharma Shares So... | 03/11/20 |
| RedHill Biopharma Ltd. (RDHL) shares are rising above 5% in pre-market today, after the company said it is actively pursuing an exploratory program in... | |
| RedHill EPS beats by $0.74, misses on re... | 03/04/20 |
| RedHill (NASDAQ:RDHL): FY GAAP EPS of -$0.14 beats by $0.74. Revenue of $6.29M (-24.8% Y/Y) misses by $0.59M. Shares +0.93% PM. Press Release | |
| The Daily Biotech Pulse: Moderna Ships C... | 02/25/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) ... | |
| RedHill Biopharma buys rights to Movanti... | 02/25/20 |
| RedHill Biopharma (NASDAQ:RDHL) says it is acquiring the global rights to Movantik (naloxegol), a peripherally acting mu-opioid receptor antagonist in... | |
| RedHill Biopharma to Discontinue Promoti... | 01/21/20 |
| RedHill Biopharma is discontining its commercialization agreements for its legacy products and focusing on its lead commercial products. The post RedH... | |
| RedHill Biopharma Regains Rights to Prop... | 01/02/20 |
| RedHill Biopharma has terminated a 2014 license agreement, regaining its exclusive rights to a proprietary formulation for bowel preparation. The post... | |
| US FDA approves RedHill's bacterial infe... | 11/04/19 |
| REUTERS: RedHill Biopharma Ltd's said on Monday its three-drug combination therapy to treat Helicobacter pylori bacterial infections had been approved... | |
| US FDA approves RedHill's H. pylori infe... | 11/04/19 |
| REUTERS: The U.S. Food and Drug Administration has approved RedHill Biopharma Ltd's drug to treat infections caused by bacteria known as Helicobacter ... | |
| Attention Biotech Investors: Mark Your C... | 11/01/19 |
| The FDA worked overtime in October , deciding on the fate of several therapies and treatment options. Most reviews produced positive outcomes. Three n... | |
| RedHill Biopharma : to Present New Phase... | 10/28/19 |
| Press Release RedHill Biopharma to Present New Phase 3 Data on RHB-105 and RHB-104 at the American College of Gastroenterology 2019??? | October 28, 2... | |
| 3 Small-Caps That Look Like Bargains at ... | 07/17/19 |
| BioDelivery Sciences International (BDSI), Beazer Homes USA (BZH) and Redhill Biopharma (RDHL) are three small-cap stocks that look like bargain at cu... | |
| RedHill Biopharma Appoints Dr. June Alme... | 05/28/19 |
| TEL-AVIV, Israel and RALEIGH, N.C., May 28, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) ("RedHill... | |
| RedHill Biopharma Expands Commercial Man... | 05/21/19 |
| Rob Jackson joins as Vice President of Marketing Robert J. Gilkin, Jr. joins as Vice President of Market Access Steven Thomasian to join as Vice Presi... | |
| RedHill Biopharma Ltd. (RDHL) CEO Dror B... | 05/07/19 |
| No summary available. | |
| RedHill files U.S. application for combo... | 05/07/19 |
| No summary available. | |
| RedHill beats by $0.32, misses on revenu... | 05/07/19 |
| No summary available. | |
| RedHill Biopharma Reports First Quarter ... | 05/07/19 |
| Key Highlights and Upcoming Milestones: NDA submitted to the FDA for Talicia ?? for H. pylori infection, with potential U.S. commercial launch in Q4/2... | |
| RedHill Biopharma to Host First Quarter ... | 04/30/19 |
| TEL-AVIV, Israel and RALEIGH, N.C., April 30, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ( Nasdaq : RDHL) (Tel-Aviv Stock Exchange: RDHL) ("RedHi... | |
| Redhill Biopharma (RDHL) Presents At H.C... | 04/09/19 |
| No summary available. | |
| Redhill Biopharma (RDHL) Presents At 31s... | 03/20/19 |
| No summary available. | |
| RedHill Biopharma's (RDHL) CEO Dror Ben-... | 02/26/19 |
| No summary available. | |
| RedHill reports FY results | 02/26/19 |
| No summary available. | |
| RedHill Bio nabs fifth U.S. patent for T... | 01/17/19 |
| No summary available. | |
| RedHill Bio nabs fifth U.S. patent for T... | 01/17/19 |
| No summary available. | |
| Date | 2020-05-27 (BMO) | Est. (EPS/Rev.) | ($0.24)/ 4.38M |
| Actual (EPS/Rev.) | $-0.05/ $1.06 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 81.00 % | Subscribe |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
